Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
Ghassan K. Abou‐Alfa, Vaibhav Sahai, Antoine Hollebecque, Gina M. Vaccaro, Davide Melisi, Raed Moh’d Taiseer Al-Rajabi, Andrew Scott Paulson, Mitesh J. Borad, David Gallinson, Adrian Murphy, Do‐Youn Oh, Efrat Dotan, Daniel V.T. Catenacci, Eric Van Cutsem, Tao Ji, Christine Lihou, Hui‐Ling Zhen, Luis Féliz, Arndt Vogel
Topics & Concepts
MedicineClinical endpointFibroblast growth factor receptorInternal medicineFibroblast growth factorPhases of clinical researchCancerToxicityGastroenterologyOncologyClinical trialReceptorFibroblast Growth Factor ResearchCholangiocarcinoma and Gallbladder Cancer StudiesIgG4-Related and Inflammatory Diseases